TREATING DIABETES AND METABOLIC SYNDROME Russian patent published in 2014 - IPC A61K38/23 A61P3/10 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutics and medicine, and concerns a pharmaceutical composition for intrajejunal administration for reducing an undesirable high serum glucose or reducing undesirable high peak serum insulin, which contains an active compound which is a representative of the calcitonin family, however is not amylin, and which is a modified representative of the calcitonin family, which has an amino acid homology of at least 75% with calcitonin, however not with amylin, and which is modified by adding, substituting or deleting amino acids and preserving an ability to bind and activate a calcitonin receptor, or a non-peptide low-molecular molecule of a calcitonin receptor agonist.

EFFECT: invention enables reducing the undesirable high serum glucose concentration.

9 cl, 12 dwg, 5 ex